Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × sargramostim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia 40 Melanoma 39 Lymphoma 38 Breast Neoplasms 31 Lymphoma, Follicular 27 Lymphoma, Non-Hodgkin 23 Leukemia, Myeloid, Acute 23 Multiple Myeloma 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Neuroblastoma 21 Leukemia, Lymphocytic, Chronic, B-Cell 21 Lymphoma, Large B-Cell, Diffuse 19 Prostatic Neoplasms 17 Lymphoma, Mantle-Cell 17 Lymphoma, Large-Cell, Immunoblastic 17 Ovarian Neoplasms 16 Lung Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Myelodysplastic Syndromes 15 Glioblastoma 15 Neoplasms, Plasma Cell 14 Neoplasm Metastasis 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Burkitt Lymphoma 14 Leukemia, Myeloid, Chronic-Phase 12 Hodgkin Disease 12 Gliosarcoma 12 Neoplasms 11 Lymphoma, B-Cell, Marginal Zone 11 Colorectal Neoplasms 11

Interventions

pembrolizumab 11 Injections 11 Paclitaxel 10 Docetaxel 9 Cisplatin 8 Capecitabine 8 Nivolumab 7 Fluorodeoxyglucose F18 7 Bevacizumab 7 toripalimab 6 senaparib 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 tislelizumab 5 Cyclophosphamide 5 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 spartalizumab 3 pertuzumab 3 olaparib 3 fludarabine 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05284214 2023-09-15

SALIENT

Partner Therapeutics, Inc.

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡